Forge Nano Reports Third Quarter 2026 Results; Raises Over $130 Million; Reiterates Guidance By FinanceWire
Forge Nano (NANO) reported Q3 2026 results, raising $130M in its Nasdaq debut. The company expects $18M revenue, $12.7M grants, and $9.4M from HZO acquisition. Key developments include a battery gigafactory, semiconductor equipment growth, and a pharma partnership with Nanexa.
How this was made
The 30-second read
Why it matters
The combination of a fresh capital raise, completed acquisition, and reiterated 2026 estimated results provides traders with updated fundamentals for valuation and near-term positioning, though key growth drivers have long lead times.
Market read
Company-specific disclosures (Q3 results, capital raise, acquisition consolidation start, and quantified 2026 outlook components) are likely to drive trading interest in NANO around guidance credibility and execution timelines.
What to watch
GAAP treatment of government grant income versus revenue could affect headline profitability optics, and HZO consolidation starts only from the Nov 4 closing date, limiting near-term earnings contribution.
Background
Forge Nano began trading on Nasdaq in October 2026 after a business combination, then completed the HZO acquisition in early November and expanded capacity across ALD systems and battery manufacturing.
Ticker impact
Forge Nano reports Q3 2026 results, raised over $130M in its Nasdaq listing, and reiterates 2026 outlook including HZO consolidation timing.
Likely upward bias as traders price in funding and clearer 2026 revenue/grant mix, tempered by uncertainty around ramp timelines (battery start in 2028, pharma equipment orders dependent on partners).
The article is company-specific and includes multiple decision-relevant disclosures: Nasdaq listing capital raise, completed HZO acquisition with consolidation from Nov 4, and reiterated 2026 estimated results with quantified components.
Market effects
Highlights continued ALD equipment demand momentum (TEPHRA capacity expansion) and potential cross-over into pharma manufacturing, which can influence sentiment toward advanced materials and semiconductor equipment peers.
Battery gigafactory expansion in North Carolina may support regional industrial and defense/aerospace supply-chain optimism.
Partnership references (Samsung SDI cell supply agreement, pharma collaborations) reinforce international supply-chain linkages for ALD manufacturing equipment.
Counterpoint
Despite the capital raise and acquisition, much of the revenue ramp appears dependent on later-stage timelines (battery production planned for 2028, pharma equipment orders contingent on downstream development and purchasing decisions).
Key entities
- companyForge Nano Holdings, Inc.
NASDAQ-listed ALD semiconductor equipment and advanced materials company reporting Q3 2026 results and reiterating 2026 outlook.
- companyHZO
Protective nanocoatings provider acquired by Forge Nano in an all-stock transaction completed Nov 4, 2026.
- companyNanexa
Partner under a joint development agreement to build GMP-compliant ALD manufacturing equipment for the PharmaShell long-acting injectable platform.
- companySamsung SDI
Strategic investor and conditional cell buyer for the Morrisville battery gigafactory expansion.


